文献速递瓣膜外科

二尖瓣手术对Barlow病患者的室性心律失常的影响:一项前瞻性研究的初步结果

The impact of mitral valve surgery on ventricular arrhythmias in patients with Barlow's disease: preliminary results of a prospective study.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2023-01-01

这项前瞻性研究纳入88例Barlow病伴显著二尖瓣反流患者,术前行动态心电图,63例完成3个月随访。基线时33%存在显著心律失常负荷,二尖瓣修复后45%的基线心律失常患者仍存在显著室性心律失常,而基线无心律失常者中18.6%出现显著室性心律失常。

要点

  • Barlow病患者中约三分之一在二尖瓣手术前存在显著心律失常负荷。
  • 二尖瓣修复后,基线心律失常患者中55%不再有显著室性心律失常。
  • 基线无心律失常者中18.6%在术后3个月出现显著室性心律失常。

核心结论

  • 在本研究经验中,因二尖瓣手术转诊的Barlow病患者约三分之一存在显著心律失常负荷,二尖瓣修复后近半数基线心律失常患者不再有显著室性心律失常,但少数基线无心律失常负荷者随访中出现显著室性心律失常。

研究设计与样本

  • 前瞻性纳入2021年2月至2022年5月转诊至本机构的88例连续Barlow病伴显著二尖瓣反流患者,所有患者术前行动态心电图监测,其中63例完成3个月超声心动图和动态心电图随访。

主要发现

  • 基线时29例(33%)为心律失常组,59例(67%)为非心律失常组,心律失常组倾向于更多为女性且有心悸史。
  • 完成3个月随访的63例中,20例(31.7%)基线为心律失常组,43例(68.3%)为非心律失常组。
  • 心律失常组中9例(45%)在二尖瓣手术后仍为心律失常组,11例(55%)转为非心律失常组。
  • 基线非心律失常组中,二尖瓣修复后8例(18.6%)转为心律失常组,35例(81.4%)仍为非心律失常组。
  • 与仍为心律失常组的患者相比,室性心律失常减少的患者术前二尖瓣脱垂(MAD)患病率更高(63.6% vs 11.1%,P = 0.028)。

关键数值与推荐

  • 显著心律失常负荷定义为≥1%室性早搏/24小时或至少一次非持续性室性心动过速(VT)、VT或心室颤动发作。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Aim of this study was to evaluate arrhythmic burden of patients with Barlow's disease and significant mitral regurgitation (MR) and assess the impact of mitral repair on ventricular arrhythmias (VA) in this group of subjects. METHODS: We prospectively included 88 consecutive patients with Barlow's disease referred to our Institution from February 2021 to May 2022. All enrolled patients underwent 24-h Holter monitoring before surgery. Sixty-three of them completed 3 months echocardiographic and Holter follow-up. Significant arrhythmic burden was defined as ≥1% premature ventricular beats/24 h or at least one episode of non-sustained ventricular tachycardia (VT), VT or ventricular fibrillation. RESULTS: At baseline, 29 patients (33%) were arrhythmogenic (AR), while 59 (67%) were not [non-arrhythmogenic (NAR)]. AR subjects tended to be more often females with history of palpitations. Sixty-three patients completed 3-months follow-up. Twenty of them (31.7%) were AR at baseline and 43 (68.3%) were not. Among AR patients, 9 (45%) remained AR after mitral surgery, while 11 (55%) became NAR. Considering NAR subjects at baseline, after mitral valve repair 8 (18.6%) evolved into AR, while 35 (81.4%) remained NAR. A higher prevalence of pre-operative MAD was found among patients experiencing VA reduction if compared with patients who remained arrhythmogenic (63.6% vs 11.1%, P = 0.028). CONCLUSIONS: In our experience, one-third of Barlow's patients referred for mitral surgery showed a significant arrhythmic burden. Almost half of the subjects arrhythmogenic at baseline were free from significant VA after mitral repair. However, a minority (18.6%) of subjects without arrhythmic burden at baseline experienced significant VA at follow-up.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ascione G, Azzola Guicciardi N, Lorusso R, et al. The impact of mitral valve surgery on ventricular arrhythmias in patients with Barlow's disease: preliminary results of a prospective study. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37166486. doi:10.1093/icvts/ivad073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。